Immunology

Making immunotherapy safe for AML

Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...

Diseases, Conditions, Syndromes

Stem cell treatment halts MS for some patients

A new study is strengthening the evidence that stem cell transplants can be highly effective for some people with multiple sclerosis—sending the disease into remission for years, and sometimes reversing disability.

Diseases, Conditions, Syndromes

Protein that drives liver damage could be a target for treatment

A severe form of fatty liver disease called nonalcoholic steatohepatitis (NASH) is the leading cause of liver transplantation, but there are few treatment options and currently no medications. In a new study, Yale researchers ...

Oncology & Cancer

Q&A: Merkel cell carcinoma

I recently heard about a type of skin cancer called Merkel cell carcinoma. I'm not familiar with this condition. Can you explain what it is? Do I need to do anything different to protect myself?

page 8 from 40